These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2845240)

  • 1. Impaired production and decreased urinary excretion of adenosine 3',5'-monophosphate in primary hyperparathyroidism with vitamin D deficiency.
    Rubinger D; Friedlaender MM; Silver J; Wald H; Shumart T; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(5):283-7. PubMed ID: 2845240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity.
    Yamashita H; Noguchi S; Moriyama T; Takamatsu Y; Sadanaga K; Uchino S; Watanabe S; Ogawa T
    Surgery; 2005 Apr; 137(4):419-25. PubMed ID: 15800489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP.
    Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E
    Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperparathyroidism masked by osteomalacia. Is vitamin D administration in every case of osteomalacia problem-free?].
    Zuber M; Löliger M; Boner H; Haas HG
    Schweiz Med Wochenschr; 1986 May; 116(19):642-7. PubMed ID: 3715442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment.
    Coen G; Bondatti F; de Matteis A; Ballanti P; Mazzaferro S; Sardella D; Smacchi A
    Miner Electrolyte Metab; 1989; 15(6):332-7. PubMed ID: 2615720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous glucagon on the urinary excretion of adenosine 3',5'-monophosphate in man and in rats. Evidence for activation of renal adenylate cyclase and formation of nephrogenous cAMP.
    Rubinger D; Wald H; Friedlaender MM; Silver J; Popovtzer MM
    Miner Electrolyte Metab; 1988; 14(4):211-20. PubMed ID: 2850459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenous cyclic adenosine monophosphate as a parathyroid function test.
    Broadus AE; Mahaffey JE; Bartter FC; Neer RM
    J Clin Invest; 1977 Oct; 60(4):771-83. PubMed ID: 197123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenous cyclic AMP levels in primary hyperparathyroidism.
    Babka JC; Bower RH; Sode J
    Arch Intern Med; 1976 Oct; 136(10):1140-4. PubMed ID: 184749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?
    Randhawa PS; Mace AD; Nouraei SA; Stearns MP
    Clin Otolaryngol; 2007 Jun; 32(3):179-84. PubMed ID: 17550505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothesis: the case for quaternary hyperparathyroidism.
    Brain HP; Sharma AK; Nussey SS
    Med Hypotheses; 2004; 62(5):701-3. PubMed ID: 15082092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum calcium, parathyroid hormone, and urinary cyclic adenosine monophosphate after parathyroidectomy.
    Kaplan EL; Fang VS; Sugimoto J; Fredland A
    Surgery; 1982 Nov; 92(5):822-6. PubMed ID: 6291182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine 3',5'-monophosphate response to parathyroid hormone: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Sharp ME; Brown EM; Gardner DG; Downs RW; Attie MF; Stock JL
    J Clin Endocrinol Metab; 1980 Mar; 50(3):546-8. PubMed ID: 6244324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired parathyroid hormone-stimulated adenosine 3',5'-monophosphate release by isolated perfused bones obtained from vitamin D-deficient rats.
    Sugimoto T; Fukase M; Tsutsumi M; Nakada M; Hishikawa R; Tsunenari T; Yoshimoto Y; Fujita T
    Endocrinology; 1986 May; 118(5):1808-13. PubMed ID: 3009136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the intravenous administration of calcium on nephrogenous cyclic AMP: use as a parathyroid suppression test.
    Broadus AE; Deftos LJ; Bartter FC
    J Clin Endocrinol Metab; 1978 Mar; 46(3):477-87. PubMed ID: 221521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gender in primary hyperparathyroidism: same disease, different presentation.
    Mazeh H; Sippel RS; Chen H
    Ann Surg Oncol; 2012 Sep; 19(9):2958-62. PubMed ID: 22535262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.